Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.

Literature DB >> 11747733

Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.

J C Hageman¹, D A Pegues, C Jepson, R L Bell, M Guinan, K W Ward, M D Cohen, J A Hindler, F C Tenover, S K McAllister, M E Kellum, S K Fridkin.

Abstract

In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types. The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission.

Entities: Chemical Species

Mesh：

Substances：

Year: 2001 PMID： 11747733 PMCID： PMC2631919 DOI： 10.3201/eid0706.010618

Source DB: PubMed Journal: Emerg Infect Dis ISSN： 1080-6040 Impact factor: 6.883

8 in total

1. Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 1997-07-11 Impact factor: 17.586

2. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 1997-07-11 Impact factor: 17.586

Review 3. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948

4. Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2000-01-07 Impact factor: 17.586

Review 5. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

Authors: S K Fridkin
Journal: Clin Infect Dis Date: 2000-12-13 Impact factor: 9.079

6. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Authors: T L Smith; M L Pearson; K R Wilcox; C Cruz; M V Lancaster; B Robinson-Dunn; F C Tenover; M J Zervos; J D Band; E White; W R Jarvis
Journal: N Engl J Med Date: 1999-02-18 Impact factor: 91.245

7. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.

Authors: S S Rotun; V McMath; D J Schoonmaker; P S Maupin; F C Tenover; B C Hill; D M Ackman
Journal: Emerg Infect Dis Date: 1999 Jan-Feb Impact factor: 6.883

8. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR.

Authors: P Vannuffel; J Gigi; H Ezzedine; B Vandercam; M Delmee; G Wauters; J L Gala
Journal: J Clin Microbiol Date: 1995-11 Impact factor: 5.948

8 in total

15 in total

Review 1. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

Authors: Catherine Liu; Henry F Chambers
Journal: Antimicrob Agents Chemother Date: 2003-10 Impact factor: 5.191

2. The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.

Authors: Dhritiman Samanta; Mohamed O Elasri
Journal: Antimicrob Agents Chemother Date: 2014-08-25 Impact factor: 5.191

3. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors: Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal: Am J Infect Control Date: 2007-12 Impact factor: 2.918

4. Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation.

Authors: Paige M Fox; Michael W Climo; Gordon L Archer
Journal: Antimicrob Agents Chemother Date: 2007-01-22 Impact factor: 5.191

5. Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients.

Authors: A Filleron; R Chiron; M-E Reverdy; H Jean-Pierre; O Dumitrescu; L Aleyrangues; F Counil; E Jumas-Bilak; H Marchandin
Journal: Eur J Clin Microbiol Infect Dis Date: 2011-09-09 Impact factor: 3.267

6. Practical strategies for detecting and confirming vancomycin-intermediate Staphylococcus aureus: a tertiary-care hospital laboratory's experience.

Authors: E M Marlowe; M D Cohen; J F Hindler; K W Ward; D A Bruckner
Journal: J Clin Microbiol Date: 2001-07 Impact factor: 5.948

7. Treatment considerations for recurrent MRSA bacteremia leading to cholecystitis.

Authors: Jenna Martin; Daniella Miller; Geraldine E Ménard
Journal: J Gen Intern Med Date: 2011-01-19 Impact factor: 5.128

8. Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities.

Authors: M P Singh; P J Petersen; W J Weiss; J E Janso; S W Luckman; E B Lenoy; P A Bradford; R T Testa; M Greenstein
Journal: Antimicrob Agents Chemother Date: 2003-01 Impact factor: 5.191

9. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors: Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal: J Clin Microbiol Date: 2003-01 Impact factor: 5.948

Review 10. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors: Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal: Clin Microbiol Rev Date: 2010-01 Impact factor: 26.132